Quality indicators of diagnosis and therapy in mri-based neoadjuvant radiochemotherapy for rectal cancer - Interim analysis of a prospective multicentre observational study (OCUM);Qualitätsindikaktoren der Diagnose und Therapie bei MRT-basierter neoadjuvanter Radiochemotherapie des Rektumkarzinoms - Interimsanalyse einer prospektiven, multizentrischen Beobachtungsstudie (OCUM)

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 138, Issue 6, 2013, Pages 630-635

  Ruppert, R ^a   Ptok, H ^b   Strassburg, J ^c   Maurer, C A ^d   Junginger, T ^e   Merkel, S ^f   Hermanek, P ^f  

^a Klinikum Neuperlach   (Germany)

^b Klinik fur Chirurgie   (Germany)

^c VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^d Chirurgische Klinik Kantonsspital Liestal   (Switzerland)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

bench marking; clinical study; neoadjuvant radiochemotherapy; quality parameters; rectal carcinoma cancer; rectum resection

Indexed keywords

ADJUVANT THERAPY; ANAL CANAL; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; GERMANY; HEALTH CARE QUALITY; HUMAN; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RECTUM; RECTUM TUMOR; TUMOR SEEDING; WOUND DEHISCENCE;

ANAL CANAL; ANASTOMOTIC LEAK; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY; NEOPLASM SEEDING; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUALITY INDICATORS, HEALTH CARE; RECTAL NEOPLASMS; RECTUM; SURGICAL WOUND DEHISCENCE;

EID: 84890570066     PISSN: 0044409X     EISSN: 14389592     Source Type: Journal    
DOI: 10.1055/s-0031-1283922     Document Type: Article

References (21)

1. Strassburg J., Ruppert R., Ptok H. et al. MRT-based indication for neoadjuvant radiochemotherapy in rectal carcinoma. Interim results of a prospective multicenter observational study. Ann Surg Oncol: 2011; 18 2790 2799
2. Bittner R., Burghardt J., Gross E. et al. Qualitätsindikatoren bei Diagnostik und Therapie des Rektumkarzinoms. Zentralblatt Chir: 2007; 132 85 94
3. Deutsche Krebsgesellschaft Erhebungsbogen für Darmzentrum der Deutschen Krebsgesellschaft. 2010; http://www.onkozert.de/downloads/eb-darm- C1(03.12.2010).doc (Zugang 04.06.2011)
4. Merkel S., Klossek D., Göhl J. et al. Quality management in rectal carcinoma: What is feasible? Int J Colorectal Dis: 2009; 24 931 942
5. Maurer C. A., Mattiello D., Duwe J. et al. Oncological short-term effects and adverse events of MR - guided selective neoadjuvant radiochemotherapy for rectal carcinoma. Anticancer Res (accepted)
6. Maughan N. J., Quirke P. Modern management of colorectal cancer - a pathologists view. Scand J Surg: 2003; 92 11 19 (Pubitemid 36406631)
7. Mawdsley S., Glynne-Jones R., Grainger J. et al. Can the histopathological assessment of the circumferential margin following pre-operative pelvic chemoradiotherapy for T3 / 4 rectal cancer predict for three year disease - free survival? Int J Radiation Oncol Biol Phys: 2005; 63 745 752 (Pubitemid 41400061)
8. Glynne-Jones R., Mawdsley S., Pearce T. et al. Alternative clinical end points in rectal cancer - are we getting closer? Ann Oncol: 2006; 17 1239 1248 (Pubitemid 44288215)
9. Nagtegaal I. D., Quirke P. What is the role of the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol: 2008; 26 1099 1107
10. Strassburg J., Junginger T., Trinh T. et al. Magnetic resonance imaging (MRT)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogat endpoint CRM status. Int J Colorectal Dis: 2008; 23 1099 1107
11. Maslekar S., Sharma A., Macdonald A. et al. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum: 2007; 50;168 175
12. Quirke P., Steel R., Monson J. et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: A prospective study using data from the MRC CR07 and NCIC-CTG C016 randomised clinical trial. Lancet: 2008; 373 821 827
13. Stelzner S., Hellmich G., Haroske G. et al. Practicability of quality goals for the treatment of rectal cancer. Int J Colorect Dis: 2010; 25 1093 1102
14. Deutsche Krebsgesellschaft Benchmarking Jahresbericht der zertifizierten Darmkrebszentren. Berlin Deutsche Krebsgesellschaft: 2011
15. Rullier A., Laurent C., Capdepont M. et al. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: Number, status and impact on survival. Am J Surg Pathol: 2008; 232 45 50
16. Chang G. J., Rodriguez-Bigas M. A., Eng C. et al. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic parameter of outcome. Cancer: 2009; 115 5432 5440
17. Gerard J. P., Azria D., Gourgou-Bourgade S. et al. Comparison of two neoadjuvant chemotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12 / 0405-Prodige 2. J Clin Oncol: 2010; 28 1638 1644
18. Wolthuis A., Penninckx F., Haustemans K. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation. Ann Surg Oncol: 2011; 18 684 690
19. ndEuropean Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol: 2009; 92 148 163
20. Burton S., Brown G., Daniels I. R. et al. MRI directed multidisciplinary team preoperative treatment strategy: The way to eliminate positive circumferential margins? Brit J Cancer: 2006; 94 351 357 (Pubitemid 43237559)
21. MERCURY Study Group Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observation study. Br Med J: 2006; 333 779 782